V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300007059 | 300005128 | 1.75 | 57.95 | Curative (C) | 2015-05-18 | 2015-05-23 | CISPLATIN + FLUOROURACIL + RT | 02 | N | 300000030 | CISPLATIN |
| 300007060 | 300005128 | 1.68 | 70.5 | Palliative (P) | 2017-02-08 | 2017-02-08 | null | N | N | 300000030 | TRIAL |
| 300007061 | 300005129 | 1.6 | 73.2 | null | 2017-08-23 | 2017-09-14 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | N | 300000468 | ETOPOSIDE |
| 300007062 | 300005130 | 1.83 | 69 | Disease modification (D) | 2019-09-16 | 2019-10-11 | Cetuximab 7 day (>Cycle 2) | 1 | N | 300000602 | CAPECITABINE + OXALIPLATIN |
| 300007063 | 300005131 | 1.82 | 0 | Palliative (P) | 2016-10-30 | 2016-11-28 | Oxaliplatin + Modified de Gramont | 02 | N | 300000615 | OXALIPLATIN + MDG |
| 300007064 | 300005132 | 1.63 | 61.9 | null | 2015-08-15 | 2015-12-03 | CARBOPLATIN + RT | N | Y | 300000934 | CARBOPLATIN |
| 300007065 | 300005132 | 1.51 | 40 | Palliative (P) | 2017-08-29 | 2018-02-09 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 300000934 | CAPECITABINE + CARBOPLATIN |
| 300007066 | 300005136 | 1.65 | 46.6 | Palliative (P) | 2015-03-09 | 2015-04-24 | Gemcitabine + Capecitabine | 02 | N | 300001222 | CISPLATIN + FLUOROURACIL |
| 300007067 | 300005137 | 1.62 | 61.9 | Palliative (P) | 2018-07-24 | 2018-07-27 | Cetuximab+Cisplatin+FU (> Cycle 2) | 2 | N | 300001258 | CISPLATIN + FLUOROURACIL |
| 300007068 | 300005137 | null | null | Palliative (P) | 2017-01-04 | 2017-01-07 | Capecitabine + Oxaliplatin 21day | 02 | N | 300001258 | CISPLATIN + FLUOROURACIL |
| 300007069 | 300005137 | 1.53 | 45.4 | Palliative (P) | 2017-10-28 | 2017-10-29 | Trial Unspecified | N | N | 300001258 | CAPECITABINE + OXALIPLATIN |
| 300007070 | 300005138 | 1.8 | 71.5 | Curative (C) | 2017-02-21 | 2017-03-01 | VAC | N | N | 300001485 | CAPECITABINE + OXALIPLATIN |
| 300007071 | 300005139 | 1.57 | null | Palliative (P) | 2017-01-08 | 2017-01-10 | PEMBROLIZUMAB | N | N | 300001503 | HYDROXYCARBAMIDE |
| 300007072 | 300005142 | 1.52 | 44.65 | Neo-adjuvant (N) | 2019-03-11 | 2019-04-26 | ECX | N | N | 300001559 | CARBOPLATIN + LIPOSOMAL DOX |
| 300007073 | 300005143 | -1 | 62.8 | Curative (C) | 2016-03-09 | 2016-04-02 | GEMCITABINE + NAB PACLITAXEL | 2 | N | 300001862 | CETUXIMAB |
| 300007074 | 300005144 | 1.63 | 46 | Disease modification (D) | 2019-03-05 | 2019-03-06 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 2 | N | 300001862 | DACARBAZINE |
| 300007075 | 300005144 | 1.73 | 60 | Palliative (P) | 2016-01-14 | 2016-01-14 | Cetuximab 7 day (>Cycle 2) | 2 | Y | 300001862 | CARBOPLATIN + CETUXIMAB + FU |
| 300007076 | 300005145 | 1.75 | null | null | 2018-07-01 | 2018-07-13 | Carboplatin + Vinorelbine Oral | N | null | 300002653 | OXALIPLATIN + MDG |
| 300007077 | 300005147 | 1.88 | 68 | Adjuvant (A) | 2017-04-01 | 2017-05-20 | Cisplatin | N | N | 300002700 | IMATINIB |
| 300007078 | 300005148 | 1.7 | 108 | Palliative (P) | 2017-01-04 | 2017-01-11 | Carboplatin + Pemetrexed | 2 | N | 300002700 | CARBOPLATIN |
| 300007079 | 300005149 | 1.46 | 57 | Curative (C) | 2017-04-06 | 2017-06-11 | CAPECITABINE + OXALIPLATIN | null | N | 300003293 | CAPECITABINE |
| 300007080 | 300005150 | 1.72 | 80.9 | Palliative (P) | 2018-09-11 | 2018-10-17 | Docetaxel | Y | N | 300003300 | TRIAL |
| 300007081 | 300007148 | 1.75 | null | Adjuvant (A) | 2017-01-09 | 2017-01-11 | CISPLATIN + FLUOROURACIL | 02 | N | 300003436 | NIVOLUMAB |
| 300007082 | 300005151 | 1.69 | 83 | Curative (C) | null | 2015-07-12 | Carboplatin AUC 6 - 10 | N | N | 300003466 | CISPLATIN + FLUOROURACIL |
| 300007083 | 300005152 | 1.83 | null | Curative (C) | 2014-06-18 | 2014-07-15 | Carboplatin AUC 2 - 5 | Y | N | 300003498 | TRIAL |
| 300007084 | 300005154 | 1.58 | 75.6 | Palliative (P) | 2019-02-13 | 2019-03-21 | Cisplatin | N | N | 300003545 | OXALIPLATIN + MDG |
| 300007085 | 300005155 | 1.79 | 62.2 | Adjuvant (A) | 2017-10-21 | 2017-10-23 | Cetuximab + Radiotherapy Maint | 02 | Y | 300003661 | CETUXIMAB + RT |
| 300007086 | 300005157 | 1.57 | 52.65 | Curative (C) | 2018-03-31 | 2018-04-06 | Cisplatin + Fluorouracil + RT 5day | 2 | Y | 300003661 | CARBOPLATIN |
| 300007087 | 300005158 | null | 72.2 | Disease modification (D) | 2017-12-09 | 2018-01-06 | Carboplatin + Paclitaxel (3 weekly) | N | null | 300003970 | FLUOROURACIL |
| 300007088 | 300005159 | 1.85 | 68.3 | Curative (C) | 2015-11-02 | 2015-11-08 | Vinorelbine (oral) | 02 | N | 300003970 | IRINOTECAN + MDG |
| 300007089 | 300005160 | 1.56 | 62.4 | Palliative (P) | 2014-02-08 | 2014-02-08 | Capecitabine (21days) + Carboplatin | N | N | 300004180 | TRIAL |
| 300007090 | 300005161 | 1.62 | 93.6 | Curative (C) | 2017-03-14 | 2017-04-25 | Cetuximab + Radiotherapy Maint | N | Y | 300004188 | CARBOPLATIN + CETUXIMAB + FU |
| 300007091 | 300005161 | 1.6 | 72.5 | Neo-adjuvant (N) | 2016-10-12 | 2016-12-10 | Trial Unspecified | 02 | N | 300004188 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007092 | 300005162 | 1.57 | 98.2 | Curative (C) | 2019-07-14 | 2019-07-15 | DAIICHI Trial | Y | N | 300004598 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007093 | 300005162 | 1.88 | 97.2 | Palliative (P) | 2019-05-07 | 2019-06-08 | Trial Unspecified | Y | N | 300004598 | OXALIPLATIN + MDG |
| 300007094 | 300005163 | 1.6 | 39 | Palliative (P) | 2016-09-23 | 2016-09-24 | Oxaliplatin + Modified de Gramont | N | N | 300004978 | CISPLATIN + FLUOROURACIL + RT |
| 300007095 | 300005165 | 1.49 | 44.7 | Palliative (P) | 2017-02-03 | 2017-04-23 | CAPECITABINE + OXALIPLATIN | N | N | 300005518 | BEVACIZUMAB |
| 300007096 | 300007154 | 1.74 | 85.85 | null | 2018-06-12 | 2018-08-18 | Trial Unspecified | null | null | 300005524 | CAPECITABINE + CARBOPLATIN |
| 300007097 | 300005170 | 1.66 | 53.4 | Disease modification (D) | 2019-04-28 | 2019-05-15 | CARBOPLATIN + RT | 02 | null | 300005623 | OXALIPLATIN + MDG |
| 300007098 | 300005170 | null | 80.5 | Curative (C) | 2018-08-27 | 2018-09-17 | Cetuximab + Radiotherapy Maint | 02 | Y | 300005623 | CISPLATIN + FLUOROURACIL + RT |
| 300007099 | 300005172 | 1.86 | 55.9 | Palliative (P) | 2017-10-05 | 2017-10-25 | Cisplatin 7 day | 02 | N | 300006258 | NOT MATCHED |
| 300007100 | 300005173 | 1.65 | 0 | Palliative (P) | 2018-04-03 | 2018-04-04 | Capecitabine | N | N | 300006487 | CAPECITABINE + OXALIPLATIN |
| 300007101 | 300005175 | null | 77.2 | Palliative (P) | 2018-04-12 | 2018-04-12 | CETUXIMAB + RT | N | N | 300006487 | TRIAL |
| 300007102 | 300005175 | 1.6 | 81.9 | Curative (C) | 2016-05-23 | 2016-06-19 | Cisplatin | 02 | N | 300006487 | RITUXIMAB |
| 300007103 | 300005176 | 1.79 | 73.1 | Palliative (P) | 2018-02-20 | 2018-02-20 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 300007478 | GEMCARBO |
| 300007104 | 300005177 | null | 77.1 | Palliative (P) | 2017-01-13 | 2017-01-13 | Trial Unspecified | 02 | N | 300007488 | CETUXIMAB |
| 300007105 | 300005178 | 1.53 | 59.8 | Palliative (P) | 2017-04-10 | 2017-04-11 | Carboplatin AUC 6 - 10 | 02 | null | 300007748 | CISPLATIN |
| 300007106 | 300005179 | 1.54 | 42.4 | Palliative (P) | 2018-02-19 | 2018-03-17 | CARBOPLATIN + CETUXIMAB + FU | N | Y | 300007885 | CETUXIMAB + RT |
| 300007107 | 300007157 | 1.84 | null | Curative (C) | 2017-09-10 | 2017-09-26 | Carboplatin + Paclitaxel (weekly) | 1 | Y | 300007936 | TRIAL |
| 300007108 | 300005181 | 1.85 | 50.9 | Palliative (P) | 2017-12-27 | 2018-01-18 | CARBOPLATIN + RT | N | N | 300007977 | OXALIPLATIN + MDG |